Renaturation separation purification method of tissue plasminogen activator mutant

A technology of plasminogen and activator, which is applied in the field of separation and purification of recombinant protein in medical biotechnology, can solve problems such as high cost, and achieve the effects of reducing loss, saving time and reducing production cost.

Inactive Publication Date: 2004-12-22
CHINA PHARM UNIV
View PDF0 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, refolding reteplase with reduced and oxidized glutathione and other refol

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Renaturation separation purification method of tissue plasminogen activator mutant

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0011] The preparation method of reteplase is as follows: the expressed reteplase engineered bacterial cells are collected, suspended in 20 mM Tris-Hcl pH8.0, ultrasonically broken and centrifuged at 12000 rpm at 4° C. for 15 minutes to collect inclusion bodies. Inclusion body solution I, its components are 6~8M urea, 10~100mM Tris-Hcl, 0.5M NaCl, 1~100mM imidazole, 0~5mM 2-mercaptoethanol pH8.0, stirred at room temperature, fully dissolved, 4 Centrifuge at 12000 rpm for 15 minutes, take the supernatant, and filter it with a 0.22um or 0.45um filter membrane to obtain a denatured reteplase solution.

[0012] The denatured reteplase was passed through the Ni solution equilibrated with solution I before 2+ -HiTrap column, after loading the sample, first use twice the column volume of solution I and solution II, the components of solution II are 6~8M urea, 10~100mM Tris-Hcl, 0.5M NaCl, 20~500mM imidazole, 0~ 100mM 2-mercaptoethanol PH7~10, wash once each, and then use six times c...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

A process for renaturating, separating and purifying the mutant of tissue plasminogen activator features that the imidazole and urea are used to make the tissue plasminogen activator 'Ruitipu enzyme' be correctly folded in order to have activity and make it be renaturated, separated and purified simultaneously.

Description

1. Technical field [0001] The invention belongs to the technical field of separation and purification of recombinant protein of medical biotechnology. 2. Background technology [0002] Reteplase is a gene recombinant human tissue plasminogen activator mutant expressed in Escherichia coli by site-directed mutagenesis technology. It is a single-chain aglycosylated polypeptide, containing 355 amino acids, and has the 1-3, 176-527 amino acid coding sequence of natural human tissue plasminogen activator (tissue plasminogen activator, t-PA). Reteplase, which only carries the kringle2 domain and protease domain of wild-type t-PA, has become a comparative therapy because of its long half-life of 16-20 minutes, faster and more thorough thrombolysis and less risk of intracranial hemorrhage. Ideal thrombolytic drug. [0003] Since reteplase contains 10 pairs of disulfide bonds, it forms inclusion bodies when expressed in Escherichia coli, and it is difficult to correctly fold and ref...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C07K1/14C12N9/00
Inventor 沈子龙廖建民孙石静张新元
Owner CHINA PHARM UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap